Publikationer av Sofia Bergström
Refereegranskade
Artiklar
[1]
S. Mravinacová et al., "CSF protein ratios with enhanced potential to reflect Alzheimer’s disease pathology and neurodegeneration," Molecular Neurodegeneration, vol. 19, no. 1, 2024.
[2]
A. Ullgren et al., "Altered plasma protein profiles in genetic FTD : a GENFI study," Molecular Neurodegeneration, vol. 18, no. 1, 2023.
[3]
G. Edfeldt et al., "Distinct cervical tissue-adherent and luminal microbiome communities correlate with mucosal host gene expression and protein levels in Kenyan sex workers," Microbiome, vol. 11, no. 1, 2023.
[4]
F. Bradley et al., "Multi-omics analysis of the cervical epithelial integrity of women using depot medroxyprogesterone acetate," PLoS Pathogens, vol. 18, no. 5, 2022.
[5]
S. Bergström et al., "A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers : a GENFI study," Molecular Neurodegeneration, vol. 16, no. 1, 2021.
[6]
J. Dillner et al., "Antibodies to SARS-CoV-2 and risk of past or future sick leave," Scientific Reports, vol. 11, no. 1, 2021.
[7]
J. Remnestål et al., "Association of CSF proteins with tau and amyloid beta levels in asymptomatic 70-year-olds," Alzheimer's Research & Therapy, vol. 13, no. 1, 2021.
[8]
W. Paslawski et al., "Cerebrospinal Fluid Proteins Altered in Corticobasal Degeneration," Movement Disorders, vol. 36, no. 5, s. 1278-1280, 2021.
[9]
M. Rohl et al., "HIV-Exposed Seronegative Sex Workers Express Low T-Cell Activation and an Intact Ectocervical Tissue Microenvironment," Vaccines, vol. 9, no. 3, 2021.
[10]
J. Dillner et al., "High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers," The Journal of Infectious Diseases, vol. 224, no. 1, s. 14-20, 2021.
[11]
S. Bergström et al., "Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease," Annals of Clinical and Translational Neurology, vol. 8, no. 7, s. 1456-1470, 2021.
[12]
S. Hober et al., "Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay," Clinical & Translational Immunology (CTI), vol. 10, no. 7, 2021.
[13]
J. Remnestål et al., "Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers," Translational Neurodegeneration, vol. 9, no. 1, 2020.
[14]
I. Markaki et al., "Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson’s Disease," Movement Disorders, 2020.
[15]
M. Dezfouli et al., "Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies," Frontiers in Immunology, vol. 11, 2020.
[16]
P. Reuterswärd et al., "Levels of human proteins in plasma associated with acute paediatric malaria," Malaria Journal, vol. 17, 2018.
Kapitel i böcker
[17]
E. Pin et al., "Array-based profiling of proteins and autoantibody repertoires in CSF," i Cerebrospinal Fluid (CSF) Proteomics, : Humana Press Inc., 2019, s. 303-318.
Icke refereegranskade
Avhandlingar
[18]
S. Bergström, "Multiplexed antibody-based protein profiling in the pursuit of CSF biomarkers for neurodegenerative diseases," Doktorsavhandling Stockholm : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2021:44, 2021.
Senaste synkning med DiVA:
2024-04-28 04:04:01